{"organizations": [], "uuid": "fd306dff726fa6419d7847ba82f45e429ebefbfc", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://www.reuters.com/resources/archive/us/20180215.html", "section_title": "Archive News &amp; Video for Thursday, 15 Feb 2018 | Reuters.com", "url": "https://www.reuters.com/article/brief-jerusalem-pharmaceuticals-fy-profi/brief-jerusalem-pharmaceuticals-fy-profit-rises-idUSFWN1Q50QS", "country": "US", "domain_rank": 408, "title": "BRIEF-Jerusalem Pharmaceuticals FY Profit Rises", "performance_score": 0, "site": "reuters.com", "participants_count": 1, "title_full": "", "spam_score": 0.416, "site_type": "news", "published": "2018-02-15T19:48:00.000+02:00", "replies_count": 0, "uuid": "fd306dff726fa6419d7847ba82f45e429ebefbfc"}, "author": "Reuters Editorial", "url": "https://www.reuters.com/article/brief-jerusalem-pharmaceuticals-fy-profi/brief-jerusalem-pharmaceuticals-fy-profit-rises-idUSFWN1Q50QS", "ord_in_thread": 0, "title": "BRIEF-Jerusalem Pharmaceuticals FY Profit Rises", "locations": [], "entities": {"persons": [], "locations": [{"name": "jerusalem", "sentiment": "none"}], "organizations": [{"name": "reuters", "sentiment": "negative"}]}, "highlightText": "", "language": "english", "persons": [], "text": "Feb 15 (Reuters) - JERUSALEM PHARMACEUTICALS CO LTD :\n* FY NET INCOME AFTER TAX $6.2 MILLION VERSUS $3.1 MILLION YEAR AGO\n* FY SALES $35.2 MILLION VERSUS $28.6 MILLION YEAR AGO Source: ( bit.ly/2EG9zAt ) Further company coverage:\n ", "external_links": ["http://thomsonreuters.com/en/about-us/trust-principles.html", "http://bit.ly/2EG9zAt"], "published": "2018-02-15T19:48:00.000+02:00", "crawled": "2018-02-16T16:45:37.034+02:00", "highlightTitle": ""}